Citigroup maintains Buy on Bausch & Lomb, raises target to C$21

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

Citigroup analyst Joanne Wuensch maintained a Buy rating on Bausch & Lomb and increased the price target to C$21 from C$19, signaling a positive valuation outlook for the stock.

powered bylight_fuzz_icon
44909207

*this image is generated using AI for illustrative purposes only.

Citigroup analyst Joanne Wuensch has maintained a Buy rating on Bausch & Lomb while raising the price target to C$21 from C$19. The adjustment reflects a revised valuation outlook for the company's stock.

Rating and Price Target Details

The research note updates the investment stance on Bausch & Lomb, retaining the Buy recommendation. The price target increase signifies an improvement in the expected share price performance.

Metric Previous New
Rating Buy Buy
Price Target C$19 C$21

Bausch & Lomb is listed on the TSX under the ticker symbol BLCO.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific factors are driving the revised valuation outlook for Bausch & Lomb?

How might Bausch & Lomb's upcoming earnings report impact the new price target?

What are the potential risks that could hinder the stock from reaching the C$21 target?

like16
dislike

Bausch + Lomb to release Q2 2026 results on July 29

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights

Bausch + Lomb Corporation is set to announce its second-quarter 2026 financial results on July 29, 2026. A conference call and live webcast are scheduled for 8 a.m. ET to discuss the results and business updates. The company provides dial-in and webcast access for participants and a replay option available until August 12, 2026.

powered bylight_fuzz_icon
44885897

*this image is generated using AI for illustrative purposes only.

Bausch + Lomb Corporation will release its second-quarter 2026 financial results on Wednesday, July 29, 2026. The company will host a conference call and live webcast at 8 a.m. ET to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch + Lomb website prior to the start of the call.

Conference Call Details

Detail Information
Date Wednesday, July 29, 2026
Time 8 a.m. ET
Webcast https://www.webcaster5.com/Webcast/Page/2883/53394
Participant Dial-in (North America) +1 (888) 506-0062
Participant Dial-in (International) +1 (973) 528-0011
Participant Access Code 415531
Replay Dial-in (North America) +1 (877) 481-4010
Replay Dial-in (International) +1 (919) 882-2331
Replay Passcode 53394 (replay available until Aug. 12, 2026)

Bausch + Lomb is a global eye health company dedicated to helping people see better to live better.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What strategic initiatives will Bausch + Lomb highlight during the business update to drive growth in the second half of 2026?

How will the company address potential supply chain challenges or market shifts affecting the global eye health sector?

What are the expected key performance indicators for Q2 2026, and how do they compare to analyst expectations?

like16
dislike